Synthetic Biology
Ginkgo Bioworks Q1 Revenues More Than Triple
The Boston-based synthetic biology and biosecurity firm beat the consensus Wall Street revenue estimate but missed on the bottom line.
Berkeley Lights Revenues Rise 9 Percent in Q1 2022
The firm reported revenue growth alongside increased operating expenses and a jump in its net loss.
RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method
Premium
The Watertown, Massachusetts-based firm is looking to develop T cell-based therapies in China, among other applications.
Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium
The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.
Elegen and Sweden's Moligo Technologies emerged from stealth at last week's Built With Biology Conference, joined by Austria's Ribbon Biolabs.
Apr 14, 2022
Apr 11, 2022
Ansa Biotechnologies Closes $68M Series A Financing
Mar 28, 2022
Ginkgo Bioworks Q4 Revenues More Than Quadruple
Mar 28, 2022
Mar 23, 2022
Codex DNA Q4 Revenues Grow 63 Percent
Mar 14, 2022
Feb 24, 2022
Berkeley Lights Q4 Revenues Grow 7 Percent
Feb 14, 2022